Scarica l'app Stockscreener
12.92
10.28%
-1.48
Dopo l'orario di chiusura:
13.17
0.25
+1.93%
Precedente Chiudi:
$14.40
Aprire:
$14.41
Volume 24 ore:
315.41K
Relative Volume:
0.87
Capitalizzazione di mercato:
$434.03M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-8.254
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
-9.46%
1M Prestazione:
+3.03%
6M Prestazione:
+19.85%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$12.76
$14.95
Intervallo di 1 settimana:
$12.76
$15.19
Portata 52W:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Nome
Mbx Biosciences Inc
Settore
Industria
Telefono
(317) 989-3100
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Confronta MBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
12.92 | 489.46M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Ripresa | Jefferies | Buy |
| 2025-08-05 | Iniziato | Mizuho | Outperform |
| 2025-07-16 | Iniziato | Oppenheimer | Outperform |
| 2025-04-10 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | JP Morgan | Overweight |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Stifel | Buy |
Mostra tutto
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Momentum Traders Eye MBX Biosciences Inc. for Quick BouncePortfolio Profit Report & Risk Managed Trade Strategies - beatles.ru
Is MBX Biosciences Inc. forming a reversal patternWeekly Profit Recap & Consistent Growth Equity Picks - Newser
Will MBX Biosciences Inc. rebound enough to break evenJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Identifying reversal signals in MBX Biosciences Inc.Weekly Investment Report & Fast Momentum Entry Tips - Newser
How hedge fund analytics apply to MBX Biosciences Inc. stockJuly 2025 Technicals & AI Driven Price Forecasts - Newser
Risk adjusted return profile for MBX Biosciences Inc. analyzedDollar Strength & Community Driven Trade Alerts - Newser
How to escape a deep drawdown in MBX Biosciences Inc.2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
Is MBX Biosciences Inc. still worth holding after the dipGold Moves & Fast Entry Momentum Trade Alerts - Newser
Does MBX Biosciences Inc. meet Warren Buffett’s criteria2025 Macro Impact & Short-Term High Return Ideas - khodrobank.com
Technical analysis overview for MBX Biosciences Inc. stockPortfolio Performance Report & Reliable Intraday Trade Plans - Newser
How does MBX Biosciences Inc. compare to its peersLayoff News & AI Driven Stock Price Forecasts - khodrobank.com
Smart tools for monitoring MBX Biosciences Inc.’s price action2025 Market Trends & Detailed Earnings Play Strategies - Newser
What technical models suggest about MBX Biosciences Inc.’s comeback2025 Retail Activity & Low Drawdown Trading Techniques - Newser
Why MBX Biosciences Inc. is moving todayEarnings Growth Report & Low Drawdown Investment Ideas - Newser
Buyout Rumor: Is MBX Biosciences Inc. trading at a discountJuly 2025 Chart Watch & Real-Time Stock Movement Alerts - khodrobank.com
What is MBX Biosciences Inc.’s book value per share2025 Dividend Review & Daily Profit Maximizing Tips - khodrobank.com
What’s the recovery path for long term holders of MBX Biosciences Inc.CEO Change & Precise Entry and Exit Recommendations - Newser
Using portfolio simulators with MBX Biosciences Inc. includedJuly 2025 Highlights & Fast Entry High Yield Tips - Newser
MBX Biosciences Inc. stock daily chart insightsJuly 2025 Breakouts & Free Community Consensus Stock Picks - Newser
What’s the beta of MBX Biosciences Inc. stockPortfolio Return Summary & Daily Profit Maximizing Tips - khodrobank.com
MBX Awaits Value-Creating Milestones, With Phase II Hypoparathyroidism Data Due Any Day - insights.citeline.com
Does MBX Biosciences Inc. show high probability of reboundWeekly Earnings Recap & Community Verified Trade Signals - Newser
What high frequency data says about MBX Biosciences Inc.2025 Support & Resistance & Stock Market Timing Techniques - Newser
Evaluating MBX Biosciences Inc. with trendline analysis2025 Market Overview & Long-Term Growth Stock Strategies - Newser
MBX Biosciences Inc. stock retracement – recovery analysis2025 Analyst Calls & Technical Confirmation Trade Alerts - Newser
MBX Biosciences Inc. stock prediction for this weekMarket Activity Recap & Long-Term Growth Portfolio Plans - Newser
How to recover losses in MBX Biosciences Inc. stockJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Macro Moves & Long-Term Growth Stock Strategies - Newser
Using economic indicators to assess MBX Biosciences Inc. potentialWatch List & Real-Time Market Sentiment Reports - Newser
Applying Wyckoff theory to MBX Biosciences Inc. stockTrade Ideas & Scalable Portfolio Growth Methods - Newser
What Technical Tools Say About MBX Biosciences Inc. Recovery2025 Biggest Moves & Smart Investment Allocation Tips - beatles.ru
Mbx Biosciences Inc Azioni (MBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mbx Biosciences Inc Azioni (MBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
| Mathers Edward T | Director |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| BASKETT FOREST | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Behbahani Ali | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Chang Carmen | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Florence Anthony A. Jr. | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):